ABSTRACT
OBJECTIVES: Urachal carcinomas (UrC) are rare non-urothelial bladder neoplasms, however the potential role for MR imaging in UrC has not been well established. Our objective was to assess the value of magnetic resonance imaging (MRI) in primary and recurrent UrC. METHODS AND MATERIALS: This retrospective single-center study included all patients with UrC that underwent MRI between January 2005 and May 2020. Two radiologists reviewed MRIs independently followed by consensus with a third radiologist. For primary UrC, tumor location, size, morphology, invasion of peritoneum and/or local structures other than bladder and concordance between Mayo stage on MRI and pathology were assessed. MRI performed for recurrent UrC evaluated the pattern of recurrence. The reference standard was histopathological analysis. RESULTS: Ninety-six patients with UrC were identified of which 17 were included (9 men and 8 women, median age 50 years [IQR 42-62]). At initial MR staging (nâ¯=â¯10), all primary UrC were located at the bladder dome with median longest axis dimension of 6.0 cm. Most (70%) were mixed solid-and-cystic. Invasion of the peritoneum and/or local structures other than bladder was identified in 30%. Concordance between consensus MRI Mayo stage and final pathologic Mayo stage was 90%. At MR restaging (nâ¯=â¯7), UrC recurrence was most commonly seen at the bladder dome (71%). Overall, MRI showed a sensitivity of 85% and specificity of 50% for detecting recurrent tumor. CONCLUSION: MRI demonstrates value in evaluation of disease extent in primary and recurrent UrC, with high concordance between Mayo stage at MRI and pathology, and in the detection of local recurrences.
Subject(s)
Carcinoma , Urinary Bladder Neoplasms , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasm Recurrence, Local/diagnostic imaging , Retrospective Studies , Urinary Bladder Neoplasms/pathologyABSTRACT
BACKGROUND AND OBJECTIVES: The standard treatment for endometrial cancer is simple hysterectomy with bilateral salpingo-oophorectomy. Patients with high risk also benefit from lumbo-aortic lymphadenectomy. High risk patients include those with grades and histologic subtypes associated with poor prognosis and depth of myometrial invasion greater than 50% (M2). To determine which patients would benefit from lumbo-aortic lymphadenectomy, the depth of myometrial invasion can be assessed by intraoperative frozen section or by magnetic resonance imaging (MRI). We aimed to determine the diagnostic yield of intraoperative frozen section and MRI for detecting the presence of M2 in patients with endometrial cancer. MATERIALS AND METHODS: This cross-sectional study included women with a histologically confirmed diagnosis of endometrial cancer who underwent baseline MRI and surgical intervention in our institution between 1 January 2010 and 31 December 2017. We reviewed the MRI studies and the intraoperative frozen section reports and compared them with the information in the histopathology report. We compared the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the two tests. We also calculated the diagnostic accuracy of each method and the percentages of underestimation and overestimation. Finally, we calculated the predictive value of MRI for the presence of M2, adjusting it for the histologic variables known to be associated with poor prognosis. RESULTS: To detect M2, MRI had 63% sensitivity, 87% specificity, 73% PPV, and 81% NPV; the diagnostic accuracy was 78.8%, with 13.12% underestimation and 8.13% overestimation of M2. Intraoperative frozen section had 69% sensitivity, 86.7% specificity, 69% PPV, and 86% NPV; the diagnostic accuracy was 81.5%, with 9.24% underestimation and 9.24% overestimation of M2. The degree of concordance between the two methods was moderate (k=0.54, p < 0.00001). CONCLUSIONS: In our experience, MRI and intraoperative frozen section have adequate diagnostic yields for determining M2, though intraoperative frozen section is slightly better. The contribution of MRI in determining the presence and the site of deep myometrial invasion, as well as the factors that can confound the diagnosis, when added to the contribution of intraoperative frozen section, means that both methods help reduce the number of unnecessary lymph node dissections and the morbidity, mortality, and health costs associated with this practice.
Subject(s)
Endometrial Neoplasms/diagnostic imaging , Endometrial Neoplasms/pathology , Frozen Sections , Magnetic Resonance Imaging , Myometrium/diagnostic imaging , Myometrium/pathology , Aged , Cross-Sectional Studies , Endometrial Neoplasms/surgery , Female , Humans , Intraoperative Period , Middle Aged , Neoplasm InvasivenessABSTRACT
One hundred and eleven measurements of cerebral blood flow (C.B.F.) were performed using the Xenon 133 inhalation method in 80 cases of spontaneous subarachnoid hemorrhage of which 59 were due to ruptured aneurysms. This method is non-traumatic, reproducible and dependable. A correlation was found between clinical condition and C.B.F. values, but in a number of cases which cannot be dismissed, very low mean C.B.F. values or ischemic foci were revealed where clinical state gave no indication. A poor correlation appeared between vasospasm seen by angiography and ischemic foci detected by isotopic technique. Patients' age influenced C.B.F. values but not clinical evolution. No correlation was found between C.B.F. values and cisternal blood seen on CT scan. C.B.F. values, measured in the first two weeks of illness, were significantly higher in those patients having favorable outcome, whatever their clinical state at the time of C.B.F. measurement (comas excluded). The figure of 60 ml/100 g/min for mean cortical flow seemed to be a critical level below which the risk of complication was greater. Below this level or in cases or ischemic foci, surgery was delayed. Thus, C.B.F. measurement promises to be a valuable prognostic tool, playing an important role in the therapeutic strategy for this type of patients.
Subject(s)
Cerebrovascular Circulation , Subarachnoid Hemorrhage/physiopathology , Adult , Blood Flow Velocity , Cerebral Cortex/blood supply , Female , Humans , Intracranial Aneurysm/diagnostic imaging , Intracranial Aneurysm/surgery , Ischemic Attack, Transient/diagnosis , Male , Middle Aged , Prognosis , Subarachnoid Hemorrhage/diagnostic imaging , Subarachnoid Hemorrhage/etiology , Subarachnoid Hemorrhage/surgery , Tomography, X-Ray Computed , Xenon RadioisotopesABSTRACT
Gliomatosis cerebri is a glial neoplastic process. It is diffusely distributed through brain structures whose anatomical configuration remains intact. Clinical diagnosis of this rare disease is difficult. The symptoms are varied and biological and radiological data are not specific. The case reported shows the characteristic features of the disease. Diagnosis was possible only on autopsy, in spite of several previous clinical and biological investigations and nuclear magnetic resonance study.
Subject(s)
Brain Neoplasms/pathology , Cerebral Cortex , Corpus Callosum , Glioma/pathology , Septum Pellucidum , Adult , Female , HumansABSTRACT
OBJECTIVE: To review the current data on the duration of an antibiotic treatment. METHODS: Analysis of recent and older articles on criteria of discontinuation of an antibiotic treatment in intensive care patients. SYNTHESIS: In intensive care patients the initiation of an antibiotic therapy is more or less codified, in spite of numerous existing problems. The duration of its maintenance, although based on scientific data depends mainly on a multitude of variables. The first step is to assess the therapeutic efficiency in considering the regression of clinical manifestations, the normalization of the acute phase reactants, the sterility of bacteriological samples and the absence of relapse at therapy discontinuation. An assessment after 48 hours is essential, in order to decide the maintenance or the modification of therapy. Finally the indication of bitherapy is considered. The theoretical duration of antibiotic therapy is determined in taking into account the involved microbial agent(s), the centre of infection, the bacterial inoculum, the patient, the presence of foreign material, and the administered antibiotic.
Subject(s)
Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/prevention & control , Critical Care , Humans , Time FactorsABSTRACT
OBJECTIVES: To evaluate the development of resistance to fosfomycin or fucidic acid in severe infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and to assess the relationship with serum levels of vancomycin METHODS: A retrospective study was performed in patients hospitalized in our intensive care unit during a 3-year period (1993-1995) who were treated for severe MRSA infection with continuous infusion vacomycin and fosfomycin or fucidic acid. We analyzed the development of resistance and serum levels of vancomycin. RESULTS: During this period, only 20 patients received continuous infusion vancomycin plus fucidic acid or fosfomycin. MSRA resistant to fucidic or fosfomycin developed in 9. Vancomycin serum levels were significantly lower in patients who developed resistance to focidic acid or fosfomycin, both during the first 5 days of treatment (16.68 +/- 1.07 micrograms/ml vs. 22.64 +/- 1.05 mg/ml, p < 0.01) and throughout treatment duration (17.29 +/- 1.07 micrograms/ml vs. 21.85 +/- 0.78 microgram/ml, p < 0.01). CONCLUSIONS: Our findings confirm that in spite of continuous vancomycin infusion at an initial rate of 2 g/24 h, Staphylococcus aureus resistance to fosfomycin or fucidic acid an develop during ongoing treatment. Vancomycin levels of at least 20 micrograms/ml should be obtained as rapidly as possible.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Multiple , Methicillin Resistance , Staphylococcal Infections/drug therapy , Vancomycin/therapeutic use , Anti-Bacterial Agents/administration & dosage , Drug Therapy, Combination/administration & dosage , Drug Therapy, Combination/therapeutic use , Female , Fosfomycin/administration & dosage , Fosfomycin/therapeutic use , Fusidic Acid/administration & dosage , Fusidic Acid/therapeutic use , Humans , Infusions, Intravenous , Male , Middle Aged , Retrospective Studies , Time Factors , Vancomycin/administration & dosageABSTRACT
La enfermedad diverticular del intestino delgado constituye una entidad de rara presentación, que suele confundirse con otras patologías más comunes cuando se complica. Los falsos divertículos son de origen primario o secundario, y asientan mayoritariamente en el duodeno. El divertículo verdadero más frecuente es el de Meckel. Las complicaciones aparecen en menos del 15% de los casos. Entre ellas, se destacan, por frecuencia, la perforación y/o inflamación, la obstrucción, el sangrado, y/o la diarrea crónica. El objetivo de este trabajo es mostrar el rol de la tomografía computada multidetector en el diagnóstico y manejo de la enfermedad diverticular del intestino delgado, exponiendo casos de la práctica diaria con correlato quirúrgico de pacientes evaluados en nuestra institución.
Small bowel diverticula is an uncommon and underdiagnosed pathology. False diverticula may be primary or secondary in origin and are frequently located in the duodenum. Meckel's diverticula is the most common true diverticula. Less than 15% of cases suffer complications, of which the following are, with decreasing frequency: inflammation and perforation, obstruction, bleeding, or chronic diarrhoea. In order to contribute to the best diagnosis and management of small-bowel diverticulosis, cases are presented that were initially evaluated with multislice computed tomography and confirmed surgically in our institution.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Diverticulitis/therapy , Diverticulitis/diagnostic imaging , Intestinal Diseases/diagnostic imaging , Intestine, Small/diagnostic imaging , Diarrhea/complications , Multidetector Computed Tomography/methods , Hemorrhage/complicationsABSTRACT
It is well known that most odorants stimulate the trigeminal system but the time course of the brain regions activated by these chemical stimulations remains poorly documented, especially regarding the trigeminal system. This functional magnetic resonance imaging (fMRI) study compares brain activations resulting from the contrast between two odorant conditions (one bimodal odor and one relatively pure olfactory stimulant) according to the duration of the stimulation (i.e. one inhalation, or three or six successive inhalations). The results show striking differences in the main brain regions activated according to these durations. The caudate nucleus and the orbitofrontal cortex are only involved in short-duration stimulations, and the posterior insular cortex and post-central gyrus (SI) are only activated by long duration stimulations. Different regions of the frontal, temporal and occipital lobe are activated depending on the duration but mainly during medium-duration stimulations. These results expand on the findings of previous studies and contribute to the description of temporal networks in trigeminal perception.
Subject(s)
Brain/physiology , Odorants , Trigeminal Nuclei/physiology , Female , Humans , Magnetic Resonance Imaging , Male , Time Factors , Young AdultSubject(s)
Buffers/therapeutic use , Cyanosis/etiology , Propranolol/therapeutic use , Tetralogy of Fallot/complications , Acidosis/complications , Angiocardiography , Cyanosis/drug therapy , Cyanosis/physiopathology , Female , Humans , Infant , Infant, Newborn , Male , Pulmonary Artery , Spasm/complicationsABSTRACT
Nuestro objetivo es describir la técnica y los hallazgos de la enterotomografía (ETC) en la hemorragia digestiva de origen oscuro (HDOO). Esta entidad constituye un sangrado digestivoque persiste o recurre sin una causa identificable tras la realización de una videoendoscopia digestiva alta (VEDA) y una colonoscopia convencional (CC). Se subclasifica en evidente (HDOOE)u oculta (HDOO-O), según la presencia o ausencia de sangrado visible en la materia fecal. En el 40-70% de los casos el sitio de la hemorragia se encuentra en el intestino delgado. En los jóvenes prevalecen los tumores como etiología, mientras que en los de mayor edad predominan las angiodisplasias intestinales. La ETC consiste en la administración de contraste neutro de alta viscosidad por vía oralpara lograr la correcta distensión de las asas del intestino delgado y/o el colon. El contraste endovenoso permite una correcta valoración y caracterización de las alteraciones con asientoen la mucosa y pared del intestino. La capacidad diagnóstica de la ETC es de aproximadamenteel 40%...
Subject(s)
Humans , Gastrointestinal Hemorrhage/diagnosis , ColonoscopyABSTRACT
Among 37 patients that are admitted for a more than 3 days breathing reanimation, 19 are ventilated with bacterial filter Pall BB 22 15 and 18 with Darex Hygrobac, exchanged every days and connected to the Y piece. In this study, 6 patients are ventilated with a humidifier (pilot population). For these 43 patients, 130 protected swabs were made with the RCS Biotest placed on the expired gaz. The day of the taking off the expiratory tube was rinsed with 100 ml of aseptic water which are strained on the membrane. The two filters give very good and comparable bacteriological results. The filters prevents nosocomial pulmonary infections making a bacterial frontier between the patient and the respirator and reducing aerial contamination from one patient to another.
Subject(s)
Cross Infection/prevention & control , Filtration/instrumentation , Respiratory Tract Infections/prevention & control , Air Microbiology , Cross Infection/microbiology , Equipment Contamination/prevention & control , Humans , Humidity , Respiratory Tract Infections/microbiology , Ventilators, MechanicalABSTRACT
The bactericidal activity of beta-lactams is time-dependent, and the time spent above the MIC (T > MIC) is the best predictor of efficacy. A prospective, randomized, open-label study was conducted in intensive care unit (ICU) patients with gram-negative rod infections to compare the efficacy of cefepime given as a continuous versus an intermittent infusion. Of the 18 patients included to date, 14 had severe pneumonia and four bacteremia. All patients received amikacin, 15 mg/kg/d, and cefepime, 4 g/d. Patients were randomized to cefepime administration as a continuous infusion (Group 1, n = 9) or as an intermittent infusion (Group 2, n = 9, 2 g every 12 h). No significant differences were found between the two groups for age, sex, initial infection, IGS II score (46 vs 48, NS) or the MIC of the gram-negative organism. Mechanical ventilation and hospital stay durations, recovery rates, and pharmacokinetic parameters (24-h AUIC, 12-h AUIC, T > MIC, and T > 5 x MIC) were compared in the two groups using the chi-square and Mann-Whitney tests. P values < 0.05 were considered statistically significant. There were no significant differences for mechanical ventilation duration, recovery rate, hospital stay duration (34 vs 36 days, NS), 24-h AUIC (624 vs 473, NS), or the 12-h AUIC (235 vs 238, NS). There were two interesting findings: T > MIC was significantly (P < 0.05) higher in Group 1 (23.84 +/- 0.2) than in Group 2 (20.7 +/- 3), and T > 5 x MIC was also significantly (P < 0.01) higher in Group 1 (23.61 +/- 0.6) than in Group 2 (16.6 +/- 6). Although clinical outcomes were similar in the two groups, it is reasonable to assume that the longer time spent with a cefepime level above the MIC in the continuous infusion group was associated with a more stable bactericidal effect.
Subject(s)
Bacteremia/drug therapy , Cephalosporins/therapeutic use , Critical Care , Gram-Negative Bacterial Infections/drug therapy , Cefepime , Cephalosporins/administration & dosage , Cephalosporins/pharmacokinetics , Drug Administration Schedule , Female , Humans , Infusions, Intravenous , Length of Stay , Male , Middle AgedABSTRACT
UNLABELLED: Vancomycin is always the drug of choice for treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in spite of his bactericidal kinetic. BACKGROUND: The aim of this study was to evaluate in vivo the improvement of bactericidal kinetic of vancomycin associated with cefpirome against MRSA infection in critically ill patients. METHODS: The prospective cross-over study was carried out in 20 patients with severe pneumonia or bacteremia. There were randomized to receive vancomycin 2 g per day (Group 1, n = 10) or vancomycin with cefpirome 2 g x 2 (Group 2, n = 10). Clinical recovery, bacteriologic parameters (bactericidal kinetic and bactericidal power in vivo at the peak and the valley), duration of ventilation and stay in ICU were comparatively explored in both groups. RESULTS: Clinical outcome did not significantly differ between Group 1 and 2. Bactericidal kinetics were better in the Group 2 (40% vs 60% after 6 hours to the dilution for 1/8e) but the difference was not significant. However, bactericidal power in sera was also better in the Group 2 with more bactericidal dilution at 1/16e (68% vs 88.8%: NS) and overall at 1/32e (10.5% vs 50%: p < 0.05) and CRP, an inflammatory marker, was significantly lower in the Group 2 than in the Group 1 (119.5 +/- 24 mg/l vs 198.6 +/- 78 mg/l: p < 0.05) on the third day.
Subject(s)
Bacteremia/drug therapy , Cephalosporins/therapeutic use , Critical Care , Drug Therapy, Combination/therapeutic use , Pneumonia, Bacterial/drug therapy , Staphylococcal Infections/drug therapy , Vancomycin/therapeutic use , Adult , Aged , Bacteremia/microbiology , Female , Humans , Male , Methicillin Resistance , Middle Aged , Pneumonia, Bacterial/microbiology , Prospective Studies , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development , Staphylococcus aureus/isolation & purification , Treatment Outcome , Vancomycin/blood , CefpiromeABSTRACT
Converging lines of evidence implicate the beta-amyloid peptide (Ass) as causative in Alzheimer's disease. We describe a novel class of compounds that reduce A beta production by functionally inhibiting gamma-secretase, the activity responsible for the carboxy-terminal cleavage required for A beta production. These molecules are active in both 293 HEK cells and neuronal cultures, and exert their effect upon A beta production without affecting protein secretion, most notably in the secreted forms of the amyloid precursor protein (APP). Oral administration of one of these compounds, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, to mice transgenic for human APP(V717F) reduces brain levels of Ass in a dose-dependent manner within 3 h. These studies represent the first demonstration of a reduction of brain A beta in vivo. Development of such novel functional gamma-secretase inhibitors will enable a clinical examination of the A beta hypothesis that Ass peptide drives the neuropathology observed in Alzheimer's disease.